Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment

Synapse

Volumn 64, Issue 7, 2010, Pages 511-519

  Zaniewska, Magdalena ^a   McCreary, Andrew C ^b   Wydra, Karolina ^a   Filip, Małgorzata ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

5 HT2 receptor ligands; Behavioral sensitization; Nicotine; Rat

Indexed keywords

1,2,3,4,8,9,10,10A OCTAHYDRO 7BH CYCLOPENTA[B][1,4]DIAZEPINO[6,7,1 HI]INDOLE; 2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; NICOTINE; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; VOLINANSERIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG SENSITIZATION; DRUG WITHDRAWAL; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RAT;

AMINOPYRIDINES; AMPHETAMINES; ANIMALS; AZEPINES; ETHYLAMINES; FLUOROBENZENES; INDOLES; MALE; MOTOR ACTIVITY; NICOTINE; NICOTINIC AGONISTS; PIPERIDINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TIME FACTORS;

EID: 77953852589     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20756     Document Type: Article

References (57)

1. Alex KD, Pehek EA. 2007. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther 113:296-320.
2. 2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants. Eur J Neurosci 20:3073-3084.
3. Azmitia EC, Segal M. 1978. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 179:641-667. (Pubitemid 8372646)
4. 2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats. Psychopharmacology 181:676-687.
5. Bankson MG, Yamamoto BK. 2004. Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release. J Neurochem 91:852-859.
6. 2A/2C receptor agonists. Psychopharmacology 179:393-401.
7. 2 receptor subtypes: A family re-united? Trends Pharmacol Sci 16:105-110.
8. 2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies. Prog Neuropsychopharmacol Biol Psychiatry 28:547-557.
9. 2C receptors in the ventral tegmental area. Neuroscience 146:286-297.
10. Corrigall WA, Coen KM. 1989. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology 99:473-478.
11. 2 receptor antagonists given in the acute withdrawal from daily cocaine injections can reverse established sensitization. Eur J Pharmacol 453:255-263.
12. De Deurwaerdère P, Navailles S, Berg KA, Clarke WP, Spampinato U. 2004. Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J Neurosci 24:3235-3241.
13. Di Giovanni G, Di Matteo V, La Grutta V, Esposito E. 2001. m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors. Neuroscience 103:111-116.
14. Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E. 2000. Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors. Brain Res 865:85-90.
15. Di Matteo V, Pierucci M, Esposito E. 2004. Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration. J Neurochem 89:418-429. (Pubitemid 38495990) (Pubitemid 38495990)
16. DiFranza JR, Wellman RJ. 2005. A sensitization-homeostasis model of nicotine craving, withdrawal, and tolerance: Integrating the clinical and basic science literature. Nicotine Tob Res 7:9-26.
17. DiFranza JR, Wellman RJ. 2007. Sensitization to nicotine: How the animal literature might inform future human research. Nicotine Tob Res 9:9-20.
18. Doherty MD, Pickel VM. 2000. Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area. Brain Res 864:176-185.
19. Dunlop J, Sabb AL, Mazandarani H, Zhang J, Kalgaonker S, Shukhina E, Sukoff S, Vogel RL, Stack G, Schechter L, Harrison BL, Rosenzweig-Lipson S. 2005. WAY-163909 [(7bR,10aR)-1,2,3,4,8,9, 10,10a-octahydro-7bH-cyclopenta[b][1, 4]diazepino[6,7,1hi] indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activity. J Pharmacol Exp Ther 313:862-869.
20. Eberle-Wang K, Mikeladze Z, Uryu K, Chesselet MF. 1997. Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats. J Comp Neurol 384:233-247.
21. Filip M, Nowak E, Papla I. 2001. On the role of serotonin2A/2C receptors in the sensitization to cocaine. J Physiol Pharmacol 52:471-481. (Pubitemid 32946285) (Pubitemid 32946285)
22. Filip M, Bubar MJ, Cunningham KA. 2004. Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: Acute and chronic pharmacological analyses. J Pharmacol Exp Ther 310:1246-1254.
23. Filip M, Frankowska M, Zaniewska M, Gołda A, Przegaliński E. 2005. The serotonergic system and its role in cocaine addiction. Pharmacol Rep 57:685-700.
24. Fletcher PJ, Grottick AJ, Higgins GA. 2002. Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology 27:576-586.
25. Fletcher PJ, Sinyard J, Higgins GA. 2006. The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists. Psychopharmacology 187:515-525.
26. Frankowska M, Filip M, Przegaliński E. 2007. Effects of GABA(B) receptor ligands in animal tests of depression and anxiety. Pharmacol Rep 59:645-655.
27. Gobert A, Rivet JM, Lejeune F, Newman-Tancredi A, Adhumeau-Auclair A, Nicolas JP, Cistarelli L, Melon C, Millan MJ. 2000. Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat. Synapse 36:205-221.
28. Goldberg SR, Henningfield JE. 1988. Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of i.v. drug injection. Pharmacol Biochem Behav 30:227-234.
29. Grottick AJ, Fletcher PJ, Higgins GA. 2000. Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior. J Pharmacol Exp Ther 295:1183-1191.
30. Grottick AJ, Corrigall WA, Higgins GA. 2001. Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine. Psychopharmacology 157:292-298.
31. 2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats. Behav Brain Res 197:323-330.
32. Herin DV, Liu S, Ullrich T, Rice KC, Cunningham KA. 2005. Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine. Psychopharmacology 178:505-513.
33. Ji SP, Zhang Y, Van Cleemput J, Jiang W, Liao M, Li L, Wan Q, Backstrom JR, Zhang X. 2006. Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse. Nat Med 12:324-329.
34. Knight AR, Misra A, Quirk K, Benwell K, Revell D, Kennett G, Bickerdike M. 2004. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors. Naunyn Schmiedebergs Arch Pharmacol 370:114-123.
35. Le Foll B, Goldberg SR. 2005. Nicotine induces conditioned place preferences over a large range of doses in rats. Psychopharmacology 178:481-492.
36. Le Foll B, Goldberg SR. 2009. Effects of nicotine in experimental animals and humans: An update on addictive properties. Handb Exp Pharmacol 192:335-367.
37. Levin ED, Slade S, Johnson M, Petro A, Horton K, Williams P, Rezvani AH, Rose JE. 2008. Ketanserin, a 5-HT(2) receptor antagonist, decreases nicotine self-administration in rats. Eur J Pharmacol 600:93-97.
38. Liu S, Cunningham KA. 2006. Serotonin2C receptors (5-HT2C R) control expression of cocaine-induced conditioned hyperactivity. Drug Alcohol Depend 81:275-282.
39. Marquis KL, Sabb AL, Logue SF, Brennan JA, Piesla MJ, Comery TA, Grauer SM, Ashby CR Jr, Nguyen HQ, Dawson LA, Barrett JE, Stack G, Meltzer HY, Harrison BL, Rosenzweig-Lipson S. 2007. WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a- Octahydro-7bHcyclopenta-[ b][1,4] diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity. J Pharmacol Exp Ther 320:486-496.
40. McMahon LR, Cunningham KA. 2001. Antagonism of 5-hydroxytryptamine( 2a) receptors attenuates the behavioral effects of cocaine in rats. J Pharmacol Exp Ther 297:357-363. (Pubitemid 32242596)
41. Miller DK, Wilkins LH, Bardo MT, Crooks PA, Dwoskin LP. 2001. Once weekly administration of nicotine produces long-lasting locomotor sensitization in rats via a nicotinic receptor-mediated mechanism. Psychopharmacology 156:469-476.
42. 2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats. Behav Pharmacol 18:791-800.
43. 2 receptor agonists on the behavioral and neurochemical consequences of repeated nicotine treatment. Eur J Pharmacol 420:45-54.
44. 1 agonist C-APB. Pharmacol Biochem Behav 63:237-243.
45. Pessia M, Jiang ZG, North RA, Johnson SW. 1994. Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res 654:324-330.
46. Pierucci M, Di Matteo V, Esposito E. 2004. Stimulation of serotonin2C receptors blocks the hyperactivation of midbrain dopamine neurons induced by nicotine administration. J Pharmacol Exp Ther 309:109-118. (Pubitemid 38393121) (Pubitemid 38393121)
47. Quarta D, Naylor CG, Stolerman IP. 2007. The serotonin 2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the fivechoice serial reaction time task and in drug discrimination. Psychopharmacology 193:391-402.
48. Rahman S, Zhang J, Corrigall WA. 2003. Effects of acute and chronic nicotine on somatodendritic dopamine release of the rat ventral tegmental area: In vivo microdialysis study. Neurosci Lett 348:61-64.
49. Robinson TE, Berridge KC. 1993. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Rev 18:247-291.
50. Rosecrans JA, Villanueva HF. 1991. Discriminative stimulus properties of nicotine: Mechanisms of transduction. NIDA Res Monogr 116:101-116. (Pubitemid 23089665)
51. Vázquez-Borsetti P, Cortés R, Artigas F. 2009. Pyramidal neurons in rat prefrontal cortex projecting to ventral tegmental area and dorsal raphe nucleus express 5-HT2A receptors. Cereb Cortex 19:1678-1686.
52. Vezina P, McGehee DS, Green WN. 2007. Exposure to nicotine and sensitization of nicotine-induced behaviors. Prog Neuropsychopharmacol Biol Psychiatry 31:1625-1638.
53. Yan Q, Reith ME, Yan S. 2000. Enhanced accumbal dopamine release following 5-HT(2A) receptor stimulation in rats pretreated with intermittent cocaine. Brain Res 863:254-258.
54. Yasuda K, Suemaru K, Araki H, Gomita Y. 2002. Effect of nicotine cessation on the central serotonergic systems in mice: involvement of 5-HT(2) receptors. Naunyn Schmiedebergs Arch Pharmacol 366:276-281.
55. 2C receptor ligands on the discriminative stimulus effects of nicotine in rats. Eur J Pharmacol 571:156-165.
56. Zaniewska M, McCreary AC, Sezer G, Przegaliński E, Filip M. 2008. Effects of agmatine on nicotine-evoked behavioral responses in rats. Pharmacol Rep 60:645-654.
57. Zaniewska M, McCreary AC, Filip M. 2009. Interactions of serotonin (5-HT)(2) receptor-targeting ligands and nicotine: Locomotor activity studies in rats. Synapse 63:653-661.